Difficult therapeutic decisions in the management of diabetic retinopathy.
Management decisions for patients with diabetic eye disease can remain difficult despite the presence of guidelines. The cases below illustrate the dilemmas about the timing of instituting insulin in patients needing laser photocoagulation for improvement of glycaemic control. The use of angiotensin-converting enzyme inhibitors for diabetic eye disease is also discussed.
Leese
G P
GP
Ninewells Hospital and Medical School, Dundee, UK. Grahaml@tuht.scot.nhs.uk
D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000503:physiopathology*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology*; D003930:Diabetic Retinopathy / Q000601:surgery / Q000628:therapy*; D005260:Female; D005907:Gliclazide / Q000627:therapeutic use; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D017075:Laser Coagulation; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D016896:Treatment Outcome
D000806:Angiotensin-Converting Enzyme Inhibitors; D005907:Gliclazide; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents